Previous Page  9 / 16 Next Page
Information
Show Menu
Previous Page 9 / 16 Next Page
Page Background

Volume 6, Issue 8(Suppl)

J Obes Weight Loss Ther 2016

ISSN: 2165-7904 JOWT, an open access journal

Page 53

Notes:

Euro Obesity 2016

October 10-12, 2016

conferenceseries

.com

7

th

Obesity & Endocrinology

Specialists Congress

October 10-12, 2016 Manchester, UK

Role of macrophage in the regulation of hepatocyte fat metabolism

Susmita Chandra

Indian Institute of Chemical Biology-CSIR, India

M

acrophage secretory products contribute to the pathogenesis of chronic liver diseases by sensing danger signals from damaged

cellsunder pathogenic inflammatory conditions like fatty liver or infection. Liver resident Kupffer cells activate inflammosome

and caspase-1 to proteolyte cytokines IL-1β and IL-18. The endogenous interleukin-1 receptor antagonist (IL-1Ra), secreted

by activated monocytes and macrophages binds to IL-1 receptors & prevents IL-1 from sending a signal to that cell. Our study

is designed to understand the molecular basis of inflammatory condition developed during fatty liver diseases which regulates

hepatocyte fat metabolism. Cultured human THP-1 cells were differentiated into macrophages and stimulated by LPS to treat with

BSA-Palmitate. The cytokines in THP-1 conditioned media (CM) were profiled by ELISA or HPLC. HepG2 cells were treated with

the CM & BSA-Palmitate. Fatty acid oxidation (FAO) was measured in HepG2. Fat deposition was qualitatively determined by Oil

Red O and Triglyceride (TG) accumulation assay. Total RNA from HepG2 cells were isolated to profile gene expressions by RTqPCR.

Some expressed proteins were determined by qPCR and immune-blotting. Recombinant IL-1 decreased FAO which was dose-

dependently reversed by IL-1Ra in HepG2 cells. IL-1Ra enriched CM from LPS stimulated THP-1 macrophage increased rate of FAO

and prevented IL-1 dependent decrease in FAO. The intracellular triglyceride levels were accordingly modulated. Thus, IL-1Ra has

an important role in controlling the fat accumulation and its metabolism in HepG2 cells. Recombinant IL-1Ra can play a potential

role in blocking inflammasome induced IL-1β dependent liver inflammation and combat the inflammatory condition developed

during fatty liver diseases.

Biography

Susmita Chandra has completed her PhD during 2011 from Jadavpur University, Kolkata, India. She is working as a Post-doctoral Fellow at Cell Biology and Physiology

Division of Indian Institute of Chemical Biology. She has 10 published papers in reputed journals and has presented her research contribution in a number of national and

international conferences. Her previous and current research contribution encompasses mainly different areas of drug development studies.

susmita2506@yahoo.com

Susmita Chandra, J Obes Weight Loss Ther 2016, 6:8(Suppl)

http://dx.doi.org/10.4172/2165-7904.C1.040